NSCLC Clinical Trials in Chongqing, Chongqing Municipality
3 recruitingChongqing, Chongqing Municipality, China
Showing 1–3 of 3 trials
Recruiting
Phase 3
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Non-small Cell Lung CancerNSCLC
Merck Sharp & Dohme LLC851 enrolled204 locationsNCT06422143
Recruiting
Phase 2
A Study of YL202 in Selected Patients With Advanced Solid Tumors
Breast CancerNSCLCHNSCC+1 more
MediLink Therapeutics (Suzhou) Co., Ltd.200 enrolled82 locationsNCT06107686
Recruiting
RecistTM Criteria in Evaluating the Efficacy of Targeted Therapy for NSCLC
NSCLCTargeted TherapyEvaluation
Xueqin Yang44 enrolled1 locationNCT06142058